Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.1727
+0.0041 (2.43%)
At close: Sep 2, 2026, 4:00 PM EDT
0.1671
-0.0056 (-3.24%)
Pre-market: Sep 3, 2026, 7:40 AM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $3.47 million as of September 2, 2026. Its market cap has decreased by -89.31% in one year.
Market Cap
3.47M
Enterprise Value
14.21M
1-Year Change
-89.31%
Ranking
Category
Stock Price
$0.17
ChartMarket Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $3.47M, a decrease of -96.64%. That is a compound annual growth rate of -44.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 3.47M | -80.96% |
| Dec 31, 2025 | 18.25M | -27.79% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| VolitionRx | 5.60M |
| WORK Medical Technology Group LTD | 5.37M |
| Phaos Technology Holdings (Cayman) Limited | 5.15M |
| Nexalin Technology | 4.99M |
| Autonomix Medical | 4.60M |
| ENvue Medical | 3.98M |
| Bluejay Diagnostics | 3.79M |
| Beyond Air | 3.50M |